HRP20080338T3 - Novi kvaternizirani kinuklidinski esteri - Google Patents

Novi kvaternizirani kinuklidinski esteri

Info

Publication number: HRP20080338T3
Authority: HR; Croatia
Prior art keywords: group; optionally substituted; group selected; alkyl; furanyl
Prior art date: 2004-03-15

Application number

HR20080338T

Other languages

English (en)

Croatian (hr)

Inventor

Dolors Fernandez Forner Maria

Prat Quinones Maria

Antonia Buil Albero Maria

Original Assignee

Laboratorios Almirall

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-15

Filing date

2005-03-10

Publication date

2008-07-31

2005-03-10 Application filed by Laboratorios Almirall filed Critical Laboratorios Almirall

2008-07-31 Publication of HRP20080338T3 publication Critical patent/HRP20080338T3/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Otolaryngology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HR20080338T 2004-03-15 2005-03-10 Novi kvaternizirani kinuklidinski esteri HRP20080338T3 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200400638A ES2239546B1 (es)	2004-03-15	2004-03-15	Nuevos esteres de quinuclidina cuaternizados.
PCT/EP2005/002523 WO2005090342A1 (en)	2004-03-15	2005-03-10	New quaternized quinuclidine esters

Publications (1)

Publication Number	Publication Date
HRP20080338T3 true HRP20080338T3 (hr)	2008-07-31

Family

ID=34955916

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20080338T HRP20080338T3 (hr)	2004-03-15	2005-03-10	Novi kvaternizirani kinuklidinski esteri

Country Status (30)

Country	Link
US (1)	US20080214600A1 (es)
EP (1)	EP1725552B1 (es)
JP (1)	JP2007529444A (es)
KR (1)	KR20070003940A (es)
CN (1)	CN1930158A (es)
AR (1)	AR048004A1 (es)
AT (1)	ATE399166T1 (es)
AU (1)	AU2005223310A1 (es)
BR (1)	BRPI0508177A (es)
CA (1)	CA2560157A1 (es)
CY (1)	CY1108324T1 (es)
DE (1)	DE602005007714D1 (es)
DK (1)	DK1725552T3 (es)
EC (1)	ECSP066770A (es)
ES (2)	ES2239546B1 (es)
HR (1)	HRP20080338T3 (es)
IL (1)	IL177341A0 (es)
MY (1)	MY142036A (es)
NO (1)	NO20064659L (es)
NZ (1)	NZ548583A (es)
PE (1)	PE20060005A1 (es)
PL (1)	PL1725552T3 (es)
PT (1)	PT1725552E (es)
RS (1)	RS50566B (es)
RU (1)	RU2382041C2 (es)
SI (1)	SI1725552T1 (es)
TW (1)	TW200604196A (es)
UA (1)	UA88634C2 (es)
WO (1)	WO2005090342A1 (es)
ZA (1)	ZA200605931B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
ES2298049B1 (es)	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
NZ578489A (en) *	2007-02-15	2011-05-27	Pulmagen Therapeutics Synergy	Heterocyclic derivatives as m3 muscarinic receptors
PT2197841E (pt)	2007-09-07	2012-01-02	Theravance Inc	Compostos contendo guanidina úteis como antagonistas do receptor muscarínico
CA2608561A1 (en) *	2007-10-29	2009-04-29	Carl Paluszkiewicz	Motorcycle wind deflector accessory support
WO2009079392A1 (en)	2007-12-14	2009-06-25	Theravance, Inc.	Amidine-containing compounds useful as muscarinic receptor antagonists
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20090326004A1 (en)	2008-06-03	2009-12-31	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
KR101290893B1 (ko) *	2009-04-09	2013-07-29	노파르티스 아게	피롤리디늄 염의 제조 방법
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
RU2015121043A (ru) *	2012-12-05	2017-01-11	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Производные фенилэтилпиридина в качестве ингибиторов PDE-4
CN103755699A (zh) *	2014-01-06	2014-04-30	万特制药(海南)有限公司	一种2-羟基-2,2-二噻吩-2-基乙酸-1-氮杂二环[2,2,2]辛-3(r)-基酯制备方法
CN103755698A (zh) *	2014-01-06	2014-04-30	万特制药(海南)有限公司	一锅法制备阿地溴铵的工艺
KR101511090B1 (ko)	2014-04-24	2015-04-10	고려대학교 산학협력단	염증성 질환의 예방 또는 치료용 약학 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1219606A (en) *	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
US4843074A (en) *	1988-05-17	1989-06-27	Marion Laboratories, Inc.	1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
NO2005012I1 (no) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EE05404B1 (et) *	2000-12-28	2011-04-15	Almirall Prodesfarma Ag	Kinuklidiini derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nhtud respiratoorsete, kuseelundite v?i mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
WO2003033495A1 (en) *	2001-10-17	2003-04-24	Ucb, S.A.	Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
ES2204295B1 (es) *	2002-07-02	2005-08-01	Almirall Prodesfarma, S.A.	Nuevos derivados de quinuclidina-amida.
AR044134A1 (es) *	2003-05-02	2005-08-24	Novartis Ag	Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.

2004
- 2004-03-15 ES ES200400638A patent/ES2239546B1/es not_active Expired - Fee Related
2005
- 2005-03-10 DK DK05729711T patent/DK1725552T3/da active
- 2005-03-10 HR HR20080338T patent/HRP20080338T3/xx unknown
- 2005-03-10 CA CA002560157A patent/CA2560157A1/en not_active Abandoned
- 2005-03-10 AT AT05729711T patent/ATE399166T1/de not_active IP Right Cessation
- 2005-03-10 AU AU2005223310A patent/AU2005223310A1/en not_active Abandoned
- 2005-03-10 SI SI200530293T patent/SI1725552T1/sl unknown
- 2005-03-10 KR KR1020067018902A patent/KR20070003940A/ko not_active Ceased
- 2005-03-10 US US10/592,787 patent/US20080214600A1/en not_active Abandoned
- 2005-03-10 JP JP2007503242A patent/JP2007529444A/ja not_active Withdrawn
- 2005-03-10 WO PCT/EP2005/002523 patent/WO2005090342A1/en not_active Ceased
- 2005-03-10 BR BRPI0508177-7A patent/BRPI0508177A/pt not_active IP Right Cessation
- 2005-03-10 PE PE2005000281A patent/PE20060005A1/es not_active Application Discontinuation
- 2005-03-10 RU RU2006136085/04A patent/RU2382041C2/ru not_active IP Right Cessation
- 2005-03-10 NZ NZ548583A patent/NZ548583A/en unknown
- 2005-03-10 EP EP05729711A patent/EP1725552B1/en not_active Expired - Lifetime
- 2005-03-10 RS RSP-2008/0334A patent/RS50566B/sr unknown
- 2005-03-10 PT PT05729711T patent/PT1725552E/pt unknown
- 2005-03-10 PL PL05729711T patent/PL1725552T3/pl unknown
- 2005-03-10 DE DE602005007714T patent/DE602005007714D1/de not_active Expired - Lifetime
- 2005-03-10 ES ES05729711T patent/ES2307168T3/es not_active Expired - Lifetime
- 2005-03-10 CN CNA2005800082369A patent/CN1930158A/zh active Pending
- 2005-03-11 AR ARP050100934A patent/AR048004A1/es unknown
- 2005-03-15 MY MYPI20051090A patent/MY142036A/en unknown
- 2005-03-15 TW TW094107865A patent/TW200604196A/zh unknown
- 2005-10-03 UA UAA200610595A patent/UA88634C2/ru unknown
2006
- 2006-07-18 ZA ZA200605931A patent/ZA200605931B/en unknown
- 2006-08-07 IL IL177341A patent/IL177341A0/en unknown
- 2006-08-14 EC EC2006006770A patent/ECSP066770A/es unknown
- 2006-10-13 NO NO20064659A patent/NO20064659L/no not_active Application Discontinuation
2008
- 2008-09-09 CY CY20081100965T patent/CY1108324T1/el unknown

Also Published As

Publication number	Publication date
CY1108324T1 (el)	2014-02-12
EP1725552B1 (en)	2008-06-25
SI1725552T1 (sl)	2008-10-31
RU2006136085A (ru)	2008-04-27
MY142036A (en)	2010-08-16
NZ548583A (en)	2010-05-28
ECSP066770A (es)	2006-11-16
AU2005223310A1 (en)	2005-09-29
PT1725552E (pt)	2008-09-18
ES2239546B1 (es)	2006-12-01
BRPI0508177A (pt)	2007-08-07
KR20070003940A (ko)	2007-01-05
PE20060005A1 (es)	2006-01-28
RU2382041C2 (ru)	2010-02-20
HK1101855A1 (en)	2007-10-26
IL177341A0 (en)	2006-12-10
CN1930158A (zh)	2007-03-14
EP1725552A1 (en)	2006-11-29
ATE399166T1 (de)	2008-07-15
ZA200605931B (en)	2007-11-28
US20080214600A1 (en)	2008-09-04
JP2007529444A (ja)	2007-10-25
RS50566B (sr)	2010-05-07
DK1725552T3 (da)	2008-10-13
PL1725552T3 (pl)	2008-12-31
TW200604196A (en)	2006-02-01
DE602005007714D1 (de)	2008-08-07
UA88634C2 (en)	2009-11-10
ES2307168T3 (es)	2008-11-16
WO2005090342A1 (en)	2005-09-29
NO20064659L (no)	2006-12-13
AR048004A1 (es)	2006-03-15
ES2239546A1 (es)	2005-09-16
CA2560157A1 (en)	2005-09-29

Publication	Publication Date	Title
HRP20080338T3 (hr)	2008-07-31	Novi kvaternizirani kinuklidinski esteri
PE20250021A1 (es)	2025-01-07	Cicloalquil 3-oxopiperazin carboxamidas y cicloheteroalquil 3-oxopiperazin carboxamidas como inhibidores de nav1.8
HRP20120202T1 (hr)	2012-03-31	AMIDOFENOKSIINDAZOLI, KORISNI KAO INHIBITORI c-MET
AR049291A1 (es)	2006-07-12	Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
BRPI0718714B8 (pt)	2021-05-25	arilamidas substituídas por tiazol e oxazol, seu uso e composição farmacêutica que as compreende
HRP20090387T1 (hr)	2009-08-31	Postupak reduciranja alfa, beta nezasićenih ketona u opioidnim sastavima
AR032072A1 (es)	2003-10-22	Derivados de quinuclidina novedosos y composiciones medicinales que los contienen
AR054090A1 (es)	2007-06-06	Derivados de quinuclidina como antagonistas del receptor muscarinico m3. composiciones farmaceuticas y proceso de obtencion
PE20190653A1 (es)	2019-05-08	Nuevos derivados de pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
NO20065613L (no)	2007-05-29	3-karbamoyl-2-pyridonderivat.
AR051735A1 (es)	2007-02-07	Inhibidores pirrolicos de la proteina quinasa erk, sintesis e intermediarios de los mismos.
AR068967A1 (es)	2009-12-23	Compuestos de ciclohexandiona, proceso para la preparacion de los mismos, compuestos intermediarios, metodo de control de hierbas y malezas, y composicion herbicida
PE20220768A1 (es)	2022-05-16	Inhibidores de molecula pequena de quinasa inductora de nf-kb
RU2012142180A (ru)	2014-04-10	Ингибиторы катехол-о-метилтрансферазы и их применение для лечения психотических расстройств
AR054035A1 (es)	2007-05-30	Derivados benzodioxano y benzodioxolano y uso de los mismos
AR029301A1 (es)	2003-06-25	Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
AR068846A1 (es)	2009-12-09	Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer
AR092045A1 (es)	2015-03-18	Combinaciones farmaceuticas
MX2009003802A (es)	2009-06-04	Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta-2 adrenergico.
AR055878A1 (es)	2007-09-12	Derivados de ciclopropanocarboxamida
AR056979A1 (es)	2007-11-07	Derivados de dihidrobenzofuranos y usos de los mismos
JP2015536974A5 (es)	2016-12-22
AR094122A1 (es)	2015-07-08	Compuestos triciclicos moduladores de la actividad de cftr
RU2011129167A (ru)	2013-01-20	Противотуберкулезная композиция, содержащая соединения оксазола
RU2006144069A (ru)	2008-08-20	Режим приема контрацептива с антагонистом рецептора прогестерона и набор для приема